These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 19159285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
    Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, Dickinson B, McSwiggen JA, Vargeese C, Bowman K, Shaffer CS, Polisky BA, Zinnen S.
    Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.
    Biomacromolecules; 2009 Jan 12; 10(1):41-8. PubMed ID: 19072631
    [Abstract] [Full Text] [Related]

  • 7. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD, Huang L.
    Mol Pharm; 2006 Jan 12; 3(5):579-88. PubMed ID: 17009857
    [Abstract] [Full Text] [Related]

  • 8. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN.
    Acc Chem Res; 2012 Jul 17; 45(7):1163-71. PubMed ID: 22568781
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
    Konishi M, Wu CH, Wu GY.
    Hepatology; 2003 Oct 17; 38(4):842-50. PubMed ID: 14512871
    [Abstract] [Full Text] [Related]

  • 10. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1351-6. PubMed ID: 16157029
    [Abstract] [Full Text] [Related]

  • 11. [RNA interference inhibits replication and expression of hepatitis B virus in mice].
    Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 09; 85(9):630-4. PubMed ID: 15949363
    [Abstract] [Full Text] [Related]

  • 12. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
    Kim HR, Kim IK, Bae KH, Lee SH, Lee Y, Park TG.
    Mol Pharm; 2008 Mar 09; 5(4):622-31. PubMed ID: 18461969
    [Abstract] [Full Text] [Related]

  • 13. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J.
    J Control Release; 2011 Dec 10; 156(2):203-11. PubMed ID: 21839126
    [Abstract] [Full Text] [Related]

  • 14. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J, Cheng WP, Gu J, Ding C, Qu X, Yang Z, O'Driscoll C.
    Eur J Pharm Sci; 2012 Apr 11; 45(5):521-32. PubMed ID: 22186295
    [Abstract] [Full Text] [Related]

  • 15. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D, Kim SI, Kim M, Park M.
    Virus Res; 2006 Aug 11; 119(2):146-53. PubMed ID: 16443303
    [Abstract] [Full Text] [Related]

  • 16. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL, Xu R, Lu ZR.
    J Control Release; 2009 Mar 19; 134(3):207-13. PubMed ID: 19135104
    [Abstract] [Full Text] [Related]

  • 17. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
    Eur J Pharm Biopharm; 2008 Nov 19; 70(3):718-25. PubMed ID: 18647651
    [Abstract] [Full Text] [Related]

  • 18. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.
    Ren GL, Bai XF, Zhang Y, Chen HM, Huang CX, Wang PZ, Li GY, Zhang Y, Lian JQ.
    Biochem Biophys Res Commun; 2005 Oct 07; 335(4):1051-9. PubMed ID: 16111658
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.